News & Updates
Filter by Specialty:
Does extended lymph node sampling increase complications?
Patients undergoing more extensive lymph node sampling during surgery for a suspected malignant paediatric renal tumour do not appear to have a higher likelihood of experiencing clinically significant complications, reveals a study.
Does extended lymph node sampling increase complications?
06 Jun 2023
Nivolumab-chemo poised to alter NSCLC treatment landscape
In the 3-year analysis of the phase III CheckMate 816 trial, neoadjuvant nivolumab plus platinum doublet chemotherapy (nivo-chemo) continued to provide durable benefit for individuals with resectable non-small-cell lung cancer (NSCLC).
Nivolumab-chemo poised to alter NSCLC treatment landscape
06 Jun 2023
Electroporation a promising way to end insulin dependency in T2D
A novel endoscopic electroporation procedure, when combined with semaglutide, can eliminate the need for insulin injections for individuals with type 2 diabetes (T2D), as shown in the results of the first-in-human EMINENT study.
Electroporation a promising way to end insulin dependency in T2D
05 Jun 2023
50-percent decrease in severity a meaningful endpoint in chronic pelvic pain
A clinically meaningful endpoint for future therapeutic trials in urological chronic pelvic pain syndrome is a decrease of 30‒50 percent in pelvic pain severity, suggests a study. Clinically significant differences for urinary symptom severity are more appropriately defined separately for males and females.
50-percent decrease in severity a meaningful endpoint in chronic pelvic pain
05 Jun 2023
OPT-302 2.0 mg plus ranibizumab leads to superior vision gains in nAMD
Treatment with 2.0-mg OPT-302, a biologic inhibitor of vascular endothelial growth factor (VEGF)-C and D, in combination with ranibizumab, an anti‒VEGF-A inhibitor, results in greater vision gains when compared with the current standard of care for neovascular age-related macular degeneration (nAMD), reports a study. In addition, the combined therapy has an acceptable safety profile.
